Patents by Inventor John R. Palmer, JR.

John R. Palmer, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10226429
    Abstract: An oral creatine formulation includes soluble creatine and polyethylene glycol, coated with an enteric coating. The most preferred soluble creatine is creatine HCl. The most preferred polyethylene glycols have an average molecular weight of from 3150 to 3685, although for particular formulation formulations and particular uses, the average molecular weight polyethylene glycols may range from 190 to 9000.
    Type: Grant
    Filed: April 20, 2010
    Date of Patent: March 12, 2019
    Assignee: CRYXA LLC
    Inventors: F. Joseph Daugherty, John R. Palmer, Jr., Michael S. Tempesta
  • Publication number: 20100203131
    Abstract: An oral creatine formulation includes soluble creatine and polyethylene glycol, coated with an enteric coating. The most preferred soluble creatine is creatine HCl. The most preferred polyethylene glycols have an average molecular weight of from 3150 to 3685, although for particular formulation formulations and particular uses, the average molecular weight polyethylene glycols may range from 190 to 9000.
    Type: Application
    Filed: April 20, 2010
    Publication date: August 12, 2010
    Inventors: F. Joseph Daugherty, John R. Palmer, JR., Michael S. Tempesta
  • Publication number: 20100203090
    Abstract: An oral creatine formulation includes soluble creatine and polyethylene glycol, coated with an enteric coating. The most preferred soluble creatine is creatine HCl. The most preferred polyethylene glycols have an average molecular weight of from 3150 to 3685, although for particular formulation formulations and particular uses, the average molecular weight polyethylene glycols may range from 190 to 9000.
    Type: Application
    Filed: April 20, 2010
    Publication date: August 12, 2010
    Inventors: F. Joseph DAUGHERTY, John R. Palmer, JR., Michael S. Tempesta
  • Publication number: 20080306159
    Abstract: An oral creatine formulation includes soluble creatine and polyethylene glycol, coated with an enteric coating. The most preferred soluble creatine is creatine HCl. The most preferred polyethylene glycols have an average molecular weight of from 3150 to 3685, although for particular formulation formulations and particular uses, the average molecular weight polyethylene glycols may range from 190 to 9000.
    Type: Application
    Filed: June 4, 2008
    Publication date: December 11, 2008
    Inventors: F. Joseph Daugherty, John R. Palmer, JR., Michael S. Tempesta